Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

THRD Third Harmonic Bio

Watchlist
18.550
-0.290-1.54%
Trading Session 09/30 12:47 ET
Giving away premium quotes worth 5000 HKD/year to unlock more data
Get NOW
High
19.743
Open
18.600
Turnover
379.81K
Low
18.550
Pre Close
18.840
Volume
19.97K
Market Cap
682.53M
P/E(TTM)
Loss
52wk High
21.490
Shares
36.79M
P/E(Static)
Loss
52wk Low
16.001
Float Cap
166.95M
Bid/Ask %
-20.00%
Historical High
21.490
Shs Float
9.00M
Volume Ratio
0.27
Historical Low
16.001
Dividend TTM
--
Div Yield TTM
--
P/B
-11.27
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.22%
Amplitude
6.33%
Avg Price
19.021
Lot Size
1
Float Cap
166.95M
Bid/Ask %
-20.00%
Historical High
21.490
Shs Float
9.00M
Volume Ratio
0.27
Historical Low
16.001
Dividend TTM
--
P/B
-11.27
Dividend LFY
--
Turnover Ratio
0.22%
Amplitude
6.33%
Avg Price
19.021
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops THB001, an oral small-molecule KIT inhibitor for the treatment of chronic urticaria, a dermatologic disease driven by mast cell activation that results in red, itchy, painful welts, or hives, as well as for airway and gastrointestinal tract indications. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was founded in 2019 and is headquartered in Cambridge, Massachusetts.
CEO: Holles, Natalie C.
Market: NASDAQ
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top